CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Update

CV Sciences, Inc. (OTCMKTS:CVSI) saw a significant increase in short interest in October. As of October 15th, there was short interest totalling 21,700 shares, an increase of 239.1% from the September 30th total of 6,400 shares. Based on an average daily volume of 253,600 shares, the short-interest ratio is presently 0.1 days.

CV Sciences Stock Performance

Shares of CVSI remained flat at $0.05 during mid-day trading on Friday. 387,938 shares of the stock traded hands, compared to its average volume of 286,547. CV Sciences has a one year low of $0.03 and a one year high of $0.10. The firm has a market capitalization of $8.71 million, a P/E ratio of -2.40 and a beta of 0.61. The stock has a 50 day moving average of $0.05 and a 200-day moving average of $0.05.

CV Sciences Company Profile

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.